Pharmaceutical company Insys allegedly pushed for higher doses of addictive opioids in order to spike sales, according to a recent report from the Senate Homeland Security and Governmental Affairs Committee’s minority staff.   Shady Tactics To Spike Sales Sales representatives for Insys were reportedly rewarded for pushing providers to write patients high-dosage prescriptions of Subsys,…

Learn More